RSLS ReShape Lifesciences Inc: Aggregate Business Assets

Graphic logo of ReShape Lifesciences (RSLS)

ReShape Lifesciences (RSLS) relies on diversified US supply chains, which minimizes logistical risks and supports margins. This price action reflects the current total asset volume at 7.71. Business stability is ensured by local manufacturing plants for weight loss systems and FDA certification. The company is currently undergoing a merger with a niche developer, focusing on resource integration.

reshapelifesciences.com (RSLS) Company Total Assets: for the period 07/04/2022 - 08/30/2025

Financial and market metric breakdowns for reshapelifesciences.com (RSLS)

- price and consensus price forecast:
Market Chart ReShape Lifesciences Inc.|RSLS - Consensus Target
- market capitalization data:
Market Value ReShape Lifesciences|RSLS - Enterprise Value
- book capitalization data:
Accounting Value of a Share ReShape Lifesciences|RSLS - Book Capitalization|Market-to-Book Ratio reshapelifesciences.com|RSLS - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio ReShape Lifesciences|RSLS - Long-Term Debt to Capital|Short-Term Debt to Capital ReShape Lifesciences Inc.|RSLS - Company Debts|Debts to Book Capitalization Ratio ReShape Lifesciences|RSLS - Company Long-Term Debts|Short-Term Debt ReShape Lifesciences
Fundamental company analysis:ReShape Lifesciences
Manufactured product of reshapelifesciences.com

Specializing in safe gastric banding via the Lap-Band system, ReShape Lifesciences (RSLS) leverages its resources to scale reversible obesity surgery methods, a trend reflected in its total assets dynamics. This metric, calculated inversely through return on assets (ROA), measures the aggregate volume of capital and liabilities, allowing investors to assess asset management efficiency and the risks of diminishing returns as the balance sheet expands.

Competing companies

Company Total Asset Base dexcom.com|Penumbra (PEN) - Cumulative Company Assets|Aggregate Business Assets Novanta Inc|Haemonetics Corp. (HAE) - Company Total Assets|Aggregate Asset Value Inspire Medical Systems Inc (INSP)|PRCT: Company Total Assets|conmed.com - Company Assets|Aggregate Company Assets Pulse Biosciences (PLSE)|INMD - Aggregate Asset Value|PMI: Company Total Assets|SRDX (Surmodics Inc.) - Company Total Assets|Aggregate Company Assets Senseonics Holdings Inc SENS|Total Asset Value of Company neuropace.com|Tactile Systems Technology - Company Total Assets|Company Assets SANUWAVE Health SNWV|Cumulative Company Assets OM (Outset)|ELMD - Company Total Assets|Cumulative Company Assets LENSAR, Inc. LNSR|RCEL - Aggregate Business Assets|profoundmedical.com - Company Total Assets|Baird Medical (BDMD) - Company Total Asset Base|Company Total Assets EDAP|Cumulative Company Assets Bovie Medical (APYX)|IceCure Medical Ltd (ICCM) - Cumulative Company Assets|Aggregate Asset Value LUNG (pulmonx.com)|TELA Bio - Aggregate Company Assets|Cumulative Company Assets CytoSorbents Corp CTSO|SRTS (Sensus Healthcare Corp) - Company Total Assets|ZYXI - Company Assets|Company Total Assets electrocore.com|Vicarious Surgical (RBOT) - Total Business Assets|IINN: Company Total Assets|Company Total Asset Base SeaStar Medical Holding Corporation|Company Total Assets IRIX (IRIDEX Corporation)|Cumulative Company Assets ibs.inc (INBS)|Company Total Assets XAIR (Beyond Air)|profusa.com - Company Total Assets|SSKN - Aggregate Company Assets|glucotrack.com (GCTK) - Aggregate Company Assets|Cumulative Company Assets NanoVibronix NAOV|Venus Concept Corporation (VERO) - Aggregate Asset Value|Company Total Assets NUWE (Nuwellis, Inc.)|Company Assets AEMD|ASXC: Aggregate Company Assets|Company Balance Sheet Assets Avinger Inc. AVGR|Cumulative Company Assets BSGM (BioSig Technologies, Inc.)|Company Total Assets Cutera Inc CUTR|Company Total Assets KNW (Know Labs, Inc.)|NARI: Company Total Asset Base|Aggregate Company Assets Nevro (NVRO)|SILK (Silk Road Medical, Inc.) - Total Asset Value of Company